A mouse model of human oral-esophageal cancer

Journal of Clinical Investigation

Volumn 110, Issue 6, 2002, Pages 761-769

  Opitz, Oliver G ^a,b,c   Harada, Hideki ^a,b   Suliman, Yasir ^a,b   Rhoades, Ben ^a,b   Sharpless, Norman E ^d   Kent, Ralph ^e   Kopelovich, Levy ^f   Nakagawa, Hiroshi ^a,b   Rustgi, Anil K ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

^e FORSYTH INSTITUTE   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DRINKING WATER; PROTEIN P53; SULINDAC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CONTROLLED STUDY; CROSS BREEDING; DISEASE COURSE; DYSPLASIA; EPSTEIN BARR VIRUS; ESOPHAGUS CARCINOMA; FEMALE; INVASIVE CARCINOMA; MALE; MOUTH CARCINOMA; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 0036736803     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215324     Document Type: Article

References (44)

1. New approaches to the understanding of the molecular basis of otal cancer
2. Genetic steps in the development of squamous cell carcinoma of the esophagus
3. Experimental carcinogenesis in the cheek pouch of the Syrian hamster
4. The effect of carcinogen (DMBA) applied to the hamster's buccal pouch in combination with croton oil
5. Evaluation of dose and treatment duration on the esophageal tumorigenicity of N-nitrosomethylbenzylamine in rats
6. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer
7. Human cyclin D1 oncogene and esophageal squamous cell carcinoma
8. Cyclin D1 overexpression in esophageal dysplasia: A possible biomarker for carcinogenesis of esophageal squamous cell carcinoma
9. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue
10. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus
11. Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma
12. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis
13. p53, the cellular gatekeeper for growth and division
14. Regulation of p53 in response to DNA damage
15. The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach
16. Transforming growth factor-alpha enhances cyclin D1 transcription through the binding of early growth response protein to a cis-regulatory element in the cyclin D1 promoter
17. Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletions
18. Arf predisposes mice to tumorigenesis
19. A CACCC box-like cis-regulatory element of the Epstein-Barr virus ED-L2 promoter interacts with a novel transcriptional factor in tissue-specific squamous epithelia
20. Overexpression of cyclin D1 in the Dami megakaryocytic cell line causes growth arrest
21. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
22. Tumor spectrum analysis in p53-mutant mice
23. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene
24. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice
25. Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia
26. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice
27. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
28. Cyclin D1 provides a link between development and oncogenesis in the retina and breast
29. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development
30. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo
31. ras activity and cyclin D1 expression: An essential mechanism of mouse skin tumor development
32. p63 expression is associated with p53 loss in oral-esophageal epithelia of p53-deficient mice
33. Spindle cell carcinoma: Ultrastructural evidence of squamous origin and collagen production by the tumor cells
34. Spindle-cell carcinoma of the upper aerodigestive tract mucosa
35. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma
36. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
37. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis
38. A critical role for telomeres in suppressing and facilitating carcinogenesis
39. Selective inactivation of p53 facilitates mouse epithelial tumor progression without chromosomal instability
40. Retention of wild-type p53 in tumors from p53 heterozygous mice: Reduction of p53 dosage can promote cancer formation
41. The murine gene p27Kip1 is haplo-insufficient for tumor suppression
42. DmpI is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas
43. Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice
44. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines